eCommons@AKU
Community Health Sciences

Department of Community Health Sciences

4-14-2020

Evaluation of computer aided detection of tuberculosis on chest
radiography among people with diabetes in Karachi Pakistan
Shifa Salman Habib
Sana Rafiq
Syed Mohammad Asad Zaidi
Rashida Abbas Ferrand
Jacob Creswell

See next page for additional authors

Follow this and additional works at: https://ecommons.aku.edu/pakistan_fhs_mc_chs_chs
Part of the Bacterial Infections and Mycoses Commons, Pulmonology Commons, and the Radiology
Commons

Authors
Shifa Salman Habib, Sana Rafiq, Syed Mohammad Asad Zaidi, Rashida Abbas Ferrand, Jacob Creswell,
Bram Van Ginneken, Wafa Zehra Jamal, Kiran Sohail Azeemi, Saira Khowaja, and Aamir Khan

www.nature.com/scientificreports

OPEN

Evaluation of computer aided
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radiography among people with
diabetes in Karachi Pakistan
Shifa Salman Habib1, Sana Rafiq1, Syed Mohammad Asad Zaidi1, Rashida Abbas Ferrand2,
Jacob Creswell 3, Bram Van Ginneken4, Wafa Zehra Jamal1*, Kiran Sohail Azeemi1,
Saira Khowaja5 & Aamir Khan5
Pakistan ranks fifth among high tuberculosis (TB) burden countries and also has seventh highest
burden for diabetes mellitus (DM). DM increases the risk of developing TB and contributes to adverse
TB treatment outcomes hence screening and integrated management for both diseases in high
burden countries is suggested. Computer-Aided Detection for TB (CAD4TB) can potentially be used
as triage tool in low resource settings to pre-screen individuals for Xpert MTB/RIF testing. The aim of
this study was to evaluate the diagnostic accuracy and performance of CAD4TB software in people
with diabetes (PWD) enrolled in a TB screening program in Karachi, Pakistan. A total of 694 individuals
with a diagnosis of DM (of whom 31.1% were newly diagnosed) were screened with CAD4TB and
simultaneously provided sputum for Xpert MTB/RIF testing. Of the 74 (10.7%) participants who had
bacteriologically positive (MTB+) results on Xpert testing, 54 (73%) had a CAD4TB score >70; and 155
(25%) participants who tested MTB-negative had scores >70. The area under the receiver operator
curve was 0.78 (95% CI: 0.77–0.80). Our study findings indicate that CAD4TB offers good diagnostic
accuracy as a triage test for TB screening among PWD using Xpert MTB/RIF as the reference standard.
Diabetes mellitus (DM) increases the risk of developing tuberculosis (TB) up to three fold and may contribute to
adverse TB treatment outcomes such as delayed sputum conversion, treatment failure, relapse and death1. Given
the high proportion of undiagnosed DM in many low and middle-income countries, screening for DM among
individuals diagnosed with TB has been recommended2,3. Despite World Health Organization (WHO) and the
International Union against Tuberculosis and Lung Disease (IUATLD) recommendations for screening followed
by integrated management of both diseases, the uptake of screening for TB among people with diabetes (PWD)
has remained low4.
Recently, there has been renewed interest in the use of chest X-rays (CXR) as a screening tool for TB, particularly in active case finding programs. Computer-Aided Detection for TB (CAD4TB) software provides automatic
readings of CXR with a higher score suggestive of TB and has the potential of being used as a triage tool in
low-resource settings to pre-screen individuals for Xpert MTB/RIF testing5. Pragmatic use of screening through
CAD4TB can result in significant savings through reduced Xpert testing specially in lower middle-income countries where high costs of Xpert testing has limited its use. It also reduces the need for an onsite radiologist for
immediate readings, which is difficult in low resource settings. Evaluations of the software, using Xpert MTB/
RIF as the reference standard have been conducted in Zambia, Bangladesh, Pakistan and most recently in Nepal
and Cameroon, reporting a diagnostic accuracy in the range 0.71–0.925–8. Studies of radiographic manifestations
of pulmonary TB in PWD report an increased frequency of lower lung field lesions, a higher frequency of cavitation, and more advanced disease9,10 yet there is almost no data on use of automated reading software for TB
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All
N (%)

<50
N (%)

50–79
N (%)

>80
N (%)

Male

374 (53.9%)

119 (51.7%)

153 (51.7%)

102 (60.7%)

Female

320 (46.1%)

111 (48.3%)

143 (48.3%)

66 (39.3%)

<20

8 (1.1%)

5 (2.2%)

1 (0.3%)

2 (1.2%)

20–39

92 (13.3%)

47 (20.4%)

27 (9.1%)

18 (10.7%)

40–59

262 (37.8%)

93 (40.4%)

111 (37.5%)

58 (34.5%)

>=60

332 (47.8%)

85 (37%)

157 (53%)

90 (53.8%)

216 (31.1%)

116 (50.4%)

54 (18.2%)

46 (27.4%)

478 (68.9%)

114 (49.6%)

242 (81.8%)

122 (72.6%)

MTB Not Detected

620 (89.34%)

223 (96.9%)

276 (93.2%)

121 (72%)

MTB Detected

74 (10.66%)

7 (3.1%)

20 (6.7%)

47 (28%)

CAD4TB Score

p-Value

Gender

0.125

Age

<0.05

Diabetes Status
RBS > 200 mg/dl
Known DM
individuals

<0.001

Xpert MTB/ RIF
Result

<0.001

Table 1. Baseline characteristics of individuals with diabetes, screened with CAD4TB at private TB diagnostic
and treatment centers in Karachi, Pakistan from July 2016 till April 2017.
No of
Total
Xpert
tests

CAD
Score

Sensitivity
(%)

Specificity
(%)

PPV
(%)

NPV
(%)

No of
Xpert
tests
saved

No triage
test

—

—

—

—

—

694

Cut-off 50

90.5%

42.4%

15.8%

97.4%

270

424

7

67

Cut-off 60

83.7%

58.6%

19.4%

96.8%

375

319

12

62

Cut-off 70

73.0%

69.5%

22.2%

95.6%

451

243

20

54

Cut-off 80

63.5%

78.7%

26.3%

94.8%

515

179

27

47

Cut-off 90

48.7%

85.8%

29.0%

93.3%

570

124

38

36

No of TB
Cases
Missed

MTB+
74

Table 2. Sensitivity, Specificity, Positive predictive Value, Negative Predictive Value at different CAD4TB score
thresholds among PWD, tested using Xpert MTB/RIF, visiting TB diagnostic and treatment centers in Karachi,
Pakistan (Q3 2016-Q2 2017).

among PWD. Glycemic control also influences radiographic manifestations of pulmonary TB in patients with
DM. Therefore, CAD4TB may have variable diagnostic accuracy and lower sensitivity among PWD.
The objective of this study was to evaluate the performance of CAD4TB software in PWD enrolled in a TB
screening program in Karachi, Pakistan.

Results

A total of 694 individuals with a diagnosis of DM [of whom 478 (68.9%) were previously known individuals
with DM and 216 (31.1%) were newly diagnosed [based on glucometer random blood sugar (RBS) testing] were
screened with CAD4TB and concurrently provided sputum for Xpert MTB/RIF testing. The median age of participants was 54 (IQR 17) years and 374 (53.9%) were male. Of the 74 (10.7%) participants who had bacteriologically
positive (MTB+) results on Xpert testing, 47 (63.5%) had a CAD4TB score >80; and 121 (19.5%) participants
who tested MTB-negative had scores >80 (Table 1).
Table 2 shows the sensitivity, specificity, positive predictive value and negative predictive value of CAD4TB
score thresholds between 50 and 90, in PWD against the reference standard of Xpert MTB/RIF. Increasing
CAD4TB score thresholds improved yield of TB case detection, with a corresponding increase in specificity and
decrease in sensitivity. CAD4TB cut-offs of 50 and 90 yielded sensitivities of 90.5% and 48.7% respectively. The
potential TB cases missed and Xpert testing yield were the lowest at the cut-off of 50 and highest at 90. Figure 1
shows the receiver operating characteristic curve for CADTB for the study participants using different CAD4TB
thresholds. The AUC was 0.78 (95% CI: 0.77–0.80). Among those who were known individuals with DM, 76%
individuals had CAD4TB score >50 relative to 46% of those with newly diagnosed DM (Fig. 2).The yield of
MTB+ among newly diagnosed DM individuals was 4.2%. The overall yield of TB among DM individuals was
10.6% (Fig. 2).
Figure 3 shows a comparison of the performance of Xpert at CAD4TB score of 70 and 50 for a hypothetical
population of 100,000 individuals with DM diagnosis. It indicates that 27% MTB positive cases will be missed
when CAD4TB cut off score is >70 in comparison to 9.5% at CAD4TB cut off score >50. The Xpert testing yield
at CAD4TB score >70 is higher (22.2%) as compared to CAD4TB cut off score >50 which was 15.8%.
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Figure 1. Area under the ROC curve using CAD4TB scores as predictor for MTB detection on Xpert MTB/RIF.

Figure 2. TB testing algorithm among DM diagnosed individuals visiting private TB diagnostic and treatment
centers in Karachi, Pakistan (Q3 2016-Q2 2017).

Discussion

To our knowledge, this is the largest study to date evaluating CAD4TB among PWD and the first study using
Xpert MTB/RIF as the reference standard in a programmatic setting. In this screening program, 74 (10.7%) of the
694 PWD undergoing TB testing were diagnosed with bacteriologically confirmed TB. A previous meta-analysis
reported a TB prevalence of 0.38–14% among PWD11. Our study findings indicate that CAD4TB offers good
diagnostic accuracy as a triage test for TB screening among PWD using Xpert MTB/RIF as the reference standard. However, in comparison with the CAD4TB evaluation conducted in Pakistan among individuals with an
unknown diabetes status that reported sensitivities in the range 91.0–97.3%, our current study shows lower sensitivities (range 48.6–90.5%) for the corresponding CAD4TB cut-offs on the same version of CAD4TB software
on the same version of CAD4TB software5. A recent study from Indonesia evaluating CAD4TB among PWD
reported an AUC of 0.89 using against the reference standard of bacteriologically and clinically confirmed TB (7
bacteriologically confirmed TB cases and 2 clinically diagnosed)12.
With an estimated 19.4 million adults with DM in Pakistan, there is an important opportunity for finding
missing cases of TB by integrating TB screening algorithm within routine management of DM patients13. This
approach, after continuous advocacy by our group is now being included as part of the National Strategic Plan for
TB control in Pakistan for implementation at the district-level.
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Figure 3. : Comparison of performance of Xpert using a CAD4TB cut off 70 (a) and 50 (b) for a hypothetical
population of 100,000 DM diagnosed individuals visiting private TB diagnostic and treatment centers in
Karachi, Pakistan.

A limitation of the current study was the utilization of patient history and random blood sugar (RBS) to identify PWD instead of more definitive diagnostic tool such as HbA1c which is comparatively more expensive hence
unaffordable for most of the visitors in our setting. In addition, the association of glycemic control with CAD4TB
scores and MTB positivity was not evaluated in this study. Another limitation of this study is that the symptoms
data was not recorded which can be an important factor in risk assessment for CAD scores and enhance the performance of the software5.
The utilization of CAD4TB as a triage tool to pre-screen PWD for Xpert MTB/RIF testing can improve
case-detection in screening programs and also potentially reduce program costs by promoting more rational
use of expensive molecular tests like Xpert MTB/RIF. CAD4TB also enables the use of CXR without the need
for expert radiology review with the added benefit of a short turnaround time making it particularly useful in
resource-limited settings. Diagnostic algorithms and CAD4TB score cut-offs to be used in PWD need to be carefully appraised along with the cost implications against the number of cases missed in a low resource, high burden
population. In addition, the effect of glycemic control on performance of CAD4TB software needs further study.
In conclusion, this study gives a broad overview of the use of CAD4TB tool in settings where universal Xpert
MTB/RIF is not feasible to identify patients with DM who are more likely to have a concomitant diagnosis of TB.

Methods

The study was conducted between July 2016 to April 2017 in 30 private TB treatment and diagnostic centers called
“Sehatmand Zindagi” (Healthy Life) Centers and in community, mobile X-ray based TB screening camps, located
in low middle-income neighborhoods. The static centers and mobile X-ray units are equipped with CAD4TB
supported digital CXR and serve as sputum collection points for Xpert MTB/RIF testing. Study participants were
part of a broad bi-directional screening program for TB and Diabetes. Individuals reporting to be known cases of
DM, currently on DM medication and those who were newly diagnosed with DM, with an RBS > 200 mg/dl on
glucometer-based testing were referred for CXR and Xpert MTB/RIF testing.
The CXRs were scored for abnormalities suggestive of pulmonary TB by CAD4TB (version 3.07, Diagnostic
Image Analysis Group, The Netherlands). Data analysis was conducted using Stata version 13. Sensitivity and
specificity were computed for different CAD4TB score cut-offs using Xpert MTB/RIF as the reference standard
and the receptor operator characteristic curves were constructed for CAD4TB.

Ethics approval and consent to participate.

Ethical approval for the study was obtained from the
Institutional Review Board of Interactive Research & Development that is registered with the Department of
Health and Human Services, USA. Informed consent was taken from the all those undergoing testing under this
program and de-identified data was utilized was analysis.
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The datasets used and analyzed during the current study are available from the corresponding author on
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